Sheaff Brock Investment Advisors’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $96.5K | Sell |
11,250
-4,500
| -29% | -$38.6K | 0.01% | 436 |
|
|
2024
Q4 | $169K | Buy |
+15,750
| New | +$169K | 0.01% | 412 |
|
|
2024
Q3 | – | Sell |
-15,250
| Closed | -$64.4K | – | 454 |
|
|
2024
Q2 | $64.4K | Sell |
15,250
-2,500
| -14% | -$10.6K | 0.01% | 435 |
|
|
2024
Q1 | $90.3K | Sell |
17,750
-19,500
| -52% | -$99.3K | 0.01% | 476 |
|
|
2023
Q4 | $347K | Buy |
37,250
+15,500
| +71% | +$144K | 0.03% | 323 |
|
|
2023
Q3 | $142K | Hold |
21,750
| – | – | 0.01% | 412 |
|
|
2023
Q2 | $177K | Hold |
21,750
| – | – | 0.01% | 425 |
|
|
2023
Q1 | $186K | Hold |
21,750
| – | – | 0.02% | 434 |
|
|
2022
Q4 | $201K | Hold |
21,750
| – | – | 0.02% | 410 |
|
|
2022
Q3 | $224K | Buy |
21,750
+2,000
| +10% | +$20.6K | 0.02% | 382 |
|
|
2022
Q2 | $198K | Sell |
19,750
-3,500
| -15% | -$35.1K | 0.02% | 418 |
|
|
2022
Q1 | $286K | Sell |
23,250
-12,870
| -36% | -$158K | 0.02% | 377 |
|
|
2021
Q4 | $626K | Buy |
36,120
+2,860
| +9% | +$49.6K | 0.04% | 234 |
|
|
2021
Q3 | $597K | Buy |
33,260
+2,190
| +7% | +$39.3K | 0.04% | 229 |
|
|
2021
Q2 | $710K | Buy |
31,070
+3,500
| +13% | +$80K | 0.05% | 210 |
|
|
2021
Q1 | $412K | Buy |
+27,570
| New | +$412K | 0.03% | 284 |
|